Assignee

Novo Nordisk Biotech, Inc.

Patents = 62

Forward Citations = 457

where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents

65 inventors (with patents filed for the assignee):

Novo Nordisk Biotech, Inc. is a leading global pharmaceutical company specializing in diabetes care. With a mission to defeat diabetes, the company focuses on developing innovative and efficient ways to manage the disease through its biotech solutions. Novo Nordisk Biotech, Inc. is committed to improving the lives of millions of people living with diabetes by providing them with quality healthcare products and services.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com